Biogen Reports Diranersen Slowed Clinical Decline on Five of Six Measures at Two Years
The 60 mg dose group showed greater slowing across five of six measures at two years compared with 18 months.
The 60 mg dose group showed greater slowing across five of six measures at two years compared with 18 months.